Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis
Abstract
Radioiodine-131 ( 131 I) is widely used for diagnosis and treatment of benign thyroid diseases. Observational studies have not been conclusive about the carcinogenic potential of 131 I and we therefore conducted a meta-analysis. We performed a literature search till September 2011 which included 131 I as a diagnostic or treatment modality ( 131 I for treatment of thyroid cancer was excluded). Data on 64 different organ or organ group subsets comprising 22 029 exposed subjects in the therapeutic cohorts and 24 799 in the diagnostic cohorts in seven studies were included. Outcome was pooled as the relative risk (RR) using both standard and bias adjusted methods. Quality assessment was performed using a study-specific instrument. No increase in overall (RR 1.06, 95% CI: 0.94–1.19), main organ group or combined organ group (four groups known to concentrate 131 I; RR 1.11, 95% CI: 0.94–1.31) risks was demonstrable. Individual organs demonstrated a higher risk for kidney (RR 1.70, 95% CI: 1.15–2.51) and thyroid (RR 1.99, 95% CI: 1.22–3.26) cancers with a strong trend for stomach cancer (RR 1.11, 95% CI: 0.92–1.33). A thyroid dose effect was seen for diagnostic doses. While there is no increase in the overall burden of cancer, an increase in risk to a few organs is seen which requires substantiation. The possible increase in thyroid cancer risk following diagnostic 131 I use should no longer be of concern given that it has effectively been replaced by the use of 99mTc-pertechnetate.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A recent meta-analysis found no increase in overall cancer risk after RAI treatment for hyperthyroidism, but a trend toward increased risk of thyroid, stomach, and kidney cancer was seen, requiring further research.
“A recent meta-analysis found no increase in the overall cancer risk after RAI treatment for hyperthyroidism; however, a trend towards increased risk of thyroid, stomach, and kidney cancer was seen, requiring further research (98).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [98]
Cites
Morris, J., & Gardner, M. J. (1988) · BMJ · doi:10.1136/bmj.296.6632.1313 · Cited by 764 · see citing works
Radiation dose to patients from radiopharmaceuticals
(1991) · Annals of the ICRP · doi:10.1016/0146-6453(91)90017-b · Cited by 565 · see citing works
DOBYNS, B. M., SHELINE, G. E., WORKMAN, J. B., TOMPKINS, E. A., McCONAHEY, W. M., & BECKER, D. V. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-6-976 · Cited by 391 · see citing works
CANCER RISKS FROM MEDICAL RADIATION
Ron, E. (2003) · Health Physics · doi:10.1097/00004032-200307000-00011 · Cited by 382 · see citing works
Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis
Takkouche, B., Cadarso-Suarez, C., & Spiegelman, D. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009981 · Cited by 380 · see citing works
Tucker, M. A., Jones, P. H. M., Boice, J. D., Robison, L. L., Stone, B. J., Stovall, M., Jenkin, R. D. T., Lubin, J. H., Baum, E. S., & Siegel, S. E. (1991) · PubMed · Cited by 306 · see citing works
Radioiodine Therapy for Hyperthyroidism
Ross, D. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1007101 · Cited by 282 · see citing works
Cancer Risk After Iodine-131 Therapy for Hyperthyroidism
Holm, L., Hall, P. S., Wiklund, K., Lundell, G. E. F., Berg, G. E. B., Bjelkengren, G., Cederquist, E., Ericsson, U.-B. C., Hallquist, A., Larsson, L.-G., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.15.1072 · Cited by 267 · see citing works
Self-citationCurrent Trends in the Management of Graves' Disease*
Solomon, B. L., Glinoer, D., Lagasse, R., & Wartofsky, L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1518 · Cited by 266 · see citing works
A Quality-Effects Model for Meta-Analysis
Doi, S. A. R., & Thalib, L. (2008) · Epidemiology · doi:10.1097/ede.0b013e31815c24e7 · Cited by 265 · see citing works
Self-citationRADIOACTIVE IODINE IN THE STUDY OF THYROID PHYSIOLOGY
HERTZ, S. (1946) · JAMA · doi:10.1001/jama.1946.02870190005002 · Cited by 264 · see citing works
Suit, H. D., Goldberg, S. N., Niemierko, A., Ancukiewicz, M., Hall, E. J., Goitein, M., Wong, W. W., & Paganetti, H. (2007) · Radiation Research · doi:10.1667/rr0527.1 · Cited by 251 · see citing works
The long-term hazards of the treatment of thyroid cancer with radioiodine
Edmonds, C. J., & Smith, T. B. (1986) · British Journal of Radiology · doi:10.1259/0007-1285-59-697-45 · Cited by 247 · see citing works
Franklyn, J. A., Maisonneuve, P., Sheppard, M. C., Betteridge, J., & Boyle, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12295-x · Cited by 242 · see citing works
Radiation Dose to Patients from Radiopharmaceuticals
Task Group of Committee 2 (1987) · Annals of the ICRP · doi:10.1016/0146-6453(87)90003-0 · Cited by 234 · see citing works
(1969) · Radiology · doi:10.1148/23.1.186b · Cited by 220 · see citing works
Read, C. H., Tansey, M. J., & Menda, Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031223 · Cited by 204 · see citing works
The cardiotoxicity of adriamycin and daunomycin in children
Gilladoga, A. C., Manuel, C., TAN, C. T. C., Wollner, N., Sternberg, S. S., & Murphy, M. L. (1976) · Cancer · doi:10.1002/1097-0142(197602)37:2+ · Cited by 171 · see citing works
IRRADIATED NEUROBLASTOMA IN CHILDHOOD AS POTENTIAL RISK FACTOR FOR SUBSEQUENT THYROID TUMOUR
de Vathaire, F., François, P., Schweisguth, O., Oberlin, O., & Le, M. H. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90445-x · Cited by 163 · see citing works
Saenger, E. L. (1968) · JAMA · doi:10.1001/jama.205.12.855 · Cited by 155 · see citing works
THE TREATMENT OF HYPERTHYROIDISM WITH RADIOACTIVE IODINE
Chapman, E. M. (1946) · JAMA · doi:10.1001/jama.1946.02870190010003 · Cited by 146 · see citing works
Increased cancer incidence after radioiodine treatment for hyperthyroidism
Metso, S., Auvinen, A. P., Huhtala, H., Salmi, J., Oksala, H., & Jaatinen, P. (2007) · Cancer · doi:10.1002/cncr.22635 · Cited by 144 · see citing works
Incidence of Leukemia Following Treatment of Hyperthyroidism
Saenger, E. L. (1968) · JAMA · doi:10.1001/jama.1968.03140380059014 · Cited by 129 · see citing works
Leukaemia incidence after iodine-131 exposure
Hall, P. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92421-b · Cited by 122 · see citing works
Self-citationLeukaemia Following Radioiodine Treatment of Thyrotoxicosis
Pochin, E. E. (1960) · BMJ · doi:10.1136/bmj.2.5212.1545 · Cited by 120 · see citing works
Dickman, P. W., Holm, L., Lundell, G., Boice, J. D., & Hall, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11258 · Cited by 118 · see citing works
Self-citationGlinoer, D., Hesch, D., Lagasse, R., & Laurberg, P. (1987) · European Journal of Endocrinology · doi:10.1530/acta.0.115s006 · Cited by 117 · see citing works
(2002) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812775726_0010 · Cited by 117 · see citing works
Radiation Hormesis: Historical Perspective and Implications for Low-Dose Cancer Risk Assessment
Vaiserman, A. M. (2010) · Dose-Response · doi:10.2203/dose-response.09-037.vaiserman · Cited by 114 · see citing works
RADIOACTIVE IODINE THERAPY AND BREAST CANCER
GOLDMAN, M. B., Maloof, F., Monson, R. R., Aschengrau, A., Cooper, D. S., & Ridgway, E. C. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114900 · Cited by 109 · see citing works
Malignant Thyroid Tumors after Iodine-131 Therapy
Holm, L., Dahlqvist, I., Israelsson, A., & Lundell, G. E. F. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007243030404 · Cited by 104 · see citing works
Graves' disease and thyroid cancer.
Behar, R., Arganini, M., Wu, T., McCormick, M., Straus, F. H., DeGroot, L. J., & Kaplan, E. L. (1986) · PubMed · Cited by 103 · see citing works
Thyroid Cancer After Diagnostic Doses of Iodine-131: A Retrospective Cohort Study
Holm, L., Wiklund, K., Lundell, G. E. F., Bergman, N., Bjelkengren, G., Cederquist, E., Ericsson, U.-B. C., Larsson, L.-G., Lidberg, M. E., Lindberg, R. S., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.14.1132 · Cited by 103 · see citing works
Cancer Incidence Following Treatment of Hyperthyroidism
Hoffman, D. A., McConahey, W. M., Fraumeni, J. F., & Kurland, L. T. (1982) · International Journal of Epidemiology · doi:10.1093/ije/11.3.218 · Cited by 96 · see citing works
Meta-analysis of heterogeneous clinical trials: An empirical example
Doi, S. A. R., Barendregt, J. J., & Mozurkewich, E. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.12.006 · Cited by 90 · see citing works
Self-citationThyroid Cancer after Diagnostic Administration of Iodine-131
Hall, P. N., Mattsson, A. F., & Boide, J. D. (1996) · Radiation Research · doi:10.2307/3579200 · Cited by 87 · see citing works
Self-citationIodine-131: optimal therapy for hyperthyroidism in children and adolescents?
Freitas, J. E., Swanson, D. P., Gross, M. D., & Sisson, J. C. (1979) · PubMed · Cited by 75 · see citing works
Cancer Risk in Individuals with Benign Thyroid Disorders
Mellemgaard, A., From, G., Jørgensen, T., Johansen, C., Olsen, J. H., & Perrild, H. (1998) · Thyroid · doi:10.1089/thy.1998.8.751 · Cited by 64 · see citing works
Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
Huysmans, D. A., Buijs, W. C. A. M., van de Ven, M. T. P., van den Broek, W. J., KLOPPENBORG, P. W. C., Hermus, A. R. M. M., & Corstens, F. H. M. (1996) · PubMed · Cited by 62 · see citing works
Underestimation of Relative Risks by Standardized Incidence Ratios for AIDS-Related Cancers
Chaturvedi, A. K., Mbulaiteye, S. M., & Engels, E. A. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.10.005 · Cited by 53 · see citing works
Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism.
Angusti, T., Codegone, A., Pellerito, R. E., & Favero, A. (2000) · PubMed · Cited by 53 · see citing works
Jamal, M. H., Doi, S. A. R., Rousseau, M., Edwards, M., Rao, C., Barendregt, J. J., Snell, L., & Meterissian, S. (2012) · British journal of surgery · doi:10.1002/bjs.8657 · Cited by 52 · see citing works
Self-citationThyroid Cancer after Diagnostic Administration of Iodine-131 in Childhood
Hahn, K. M., Schnell‐Inderst, P., Grosche, B., & Holm, L. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)156[0061:tcadao]2.0.co;2 · Cited by 47 · see citing works
Tominaga, T., Yokoyama, N., Nagataki, S., CHO, B. Y., Koh, C., CHEN, J.-L., & SHI, Y. (1997) · Thyroid · doi:10.1089/thy.1997.7.217 · Cited by 37 · see citing works
Age-Dependent Thyroid Absorbed Doses for Radiobiologically Significant Radioisotopes of Iodine
ZANZONICO, P. B. (2000) · Health Physics · doi:10.1097/00004032-200001000-00010 · Cited by 31 · see citing works
Breast Cancer in Hypothyroid Women Using Thyroid Supplements
Hoffman, D. A. (1984) · JAMA · doi:10.1001/jama.1984.03340290030015 · Cited by 28 · see citing works
Management of Graves' disease in Australia
Walsh, J. P. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb00856.x · Cited by 27 · see citing works
Incidence of Malignant Neoplasms of All Types in Patients With Graves' Disease
Munoz, J. M. (1978) · Archives of Internal Medicine · doi:10.1001/archinte.1978.03630310034015 · Cited by 25 · see citing works
Breast Cancer Following Iodine-131 Therapy for Hyperthyroidism
3, D. A. H., & McConahey, W. M. (1983) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/70.1.63 · Cited by 24 · see citing works
Thyroid carcinoma after radioactive iodine therapy for Graves' disease
Ozaki, O., Ito, K., Mimura, T., Sugino, K., Kitamura, Y., Iwabuchi, H., & Kawano, M. (1994) · World Journal of Surgery · doi:10.1007/bf00353753 · Cited by 23 · see citing works
Luster, M., Laßmann, M., Reiners, C., & Verburg, F. A. (2010) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-0341-10-08 · Cited by 23 · see citing works
Cancer in iodine-131 exposed patients
Hall, P. N., & Holm, L. E. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349726 · Cited by 21 · see citing works
Self-citationLong-term risks in hyperthyroid patients treated with radioiodine: is there anything new?
Lucignani, G. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0509-z · Cited by 17 · see citing works
Chronic myeloid leukaemia following radioiodine therapy for carcinoma thyroid
Bundi, R. S., Scott, J. S., & Halnan, K. E. (1977) · British Journal of Radiology · doi:10.1259/0007-1285-50-589-61 · Cited by 13 · see citing works
Thyroid Carcinoma after Radioiodide Therapy for Hyperthyroidism
Spencer, R. P., CHAPMAN, C. N., & Rao, H. (1983) · Clinical Nuclear Medicine · doi:10.1097/00003072-198305000-00007 · Cited by 12 · see citing works
Acute Granulocytic Leukemia after Radioactive-Iodine Therapy for Hyperthyroidism
Kennedy, W. M., & Fish, R. G. (1959) · New England Journal of Medicine · doi:10.1056/nejm195901082600207 · Cited by 11 · see citing works
Survey of Radioiodine Therapy Safety Practices Highlights the Need for User-Friendly Recommendations
Kloos, R. T. (2011) · Thyroid · doi:10.1089/thy.2010.2102.com · Cited by 9 · see citing works
LEUKEMIA AFTER RADIOIODINE THERAPY FOR HYPERTHYROIDISM.
McCormack, K. R., & Sheline, G. E. (1963) · PubMed · Cited by 7 · see citing works
Radiation and Public Perception
Young1, J. P., & Yalow, R. S. (1995) · Advances in chemistry series · doi:10.1021/ba-1995-0243 · Cited by 2 · see citing works
Listewnik, M. H., Birkenfeld, B., Chosia, M., Elbl, B., Niedziałkowska, K., & Sawrymowicz, M. (2010) · PubMed · Cited by 2 · see citing works
Re: Cancer Risk After Iodine-131 Therapy for Hyperthyrodism
Meyer, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.13.1026 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 62 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
“A recent meta-analysis found no increase in the overall cancer risk after RAI treatment for hyperthyroidism; however, a trend towards increased risk of thyroid, stomach, and kidney cancer was seen, requiring further research (98).”
BackgroundWorldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
Pellegriti, G., Frasca, F., Regalbuto, C., Squatrito, S., & Vigneri, R. (2013) · Journal of Cancer Epidemiology · doi:10.1155/2013/965212 · Cited by 1,292 · see citing works
Management of Graves Thyroidal and Extrathyroidal Disease: An Update
Kahaly, G. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa646 · Cited by 232 · see citing works
Increasing incidence of thyroid cancer: controversies explored
Ito, Y., Nikiforov, Y. E., Schlumberger, M. J., & Vigneri, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.257 · Cited by 132 · see citing works
Azizi, F., Amouzegar, A., Tohidi, M., Hedayati, M., Khalili, D., Cheraghi, L., Mehrabi, Y., & Takyar, M. (2019) · Thyroid · doi:10.1089/thy.2019.0180 · Cited by 121 · see citing works
Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women
Journy, N., Bernier, M., Doody, M. M., Alexander, B. H., Linet, M. S., & Kitahara, C. M. (2017) · Thyroid · doi:10.1089/thy.2017.0063 · Cited by 119 · see citing works
Long-Term Antithyroid Drug Treatment: A Systematic Review and Meta-Analysis
Azizi, F., & Malboosbaf, R. (2017) · Thyroid · doi:10.1089/thy.2016.0652 · Cited by 114 · see citing works
Roberts, M. J., Williamson, D. A., Hadway, P., Doi, S. A. R., Gardiner, R. A., & Paterson, D. L. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.008 · Cited by 101 · see citing works
Self-citationRisk Factors for Thyroid Cancer: What Do We Know So Far?
Crnčić, T. B. (2020) · Acta Clinica Croatica · doi:10.20471/acc.2020.59.s1.08 · Cited by 99 · see citing works
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · Thyroid · doi:10.1089/thy.2012.0500 · Cited by 86 · see citing works
Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism
Shim, S., Kitahara, C., Cha, E., Kim, S.-J., Ye, J.-B., & Lee, W. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.25072 · Cited by 63 · see citing works
Bartalena, L., Chiovato, L., & Vitti, P. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0505-x · Cited by 75 · see citing works
Doubleday, A. R., & Sippel, R. S. (2020) · Gland Surgery · doi:10.21037/gs.2019.11.01 · Cited by 69 · see citing works
Safety of long-term antithyroid drug treatment? A systematic review
Azizi, F., & Malboosbaf, R. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01054-1 · Cited by 64 · see citing works
Superoxide Production by a Manganese-Oxidizing Bacterium Facilitates Iodide Oxidation
Li, H.-P., Daniel, B., Creeley, D., Grandbois, R., Zhang, S., Xu, C., Ho, Y., Schwehr, K. A., Kaplan, D. I., Santschi, P. H., et al. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.00400-14 · Cited by 55 · see citing works
Ryödi, E., Metso, S., Jaatinen, P., Huhtala, H., Saaristo, R., Välimäki, M. J., & Auvinen, A. P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1874 · Cited by 53 · see citing works
Chuang, S., Wu, G.-J., Lu, Y., Lin, C., & Hsiung, C. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143410 · Cited by 41 · see citing works
Thyrotoxicosis – investigation and management
Gilbert, J. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-3-274 · Cited by 40 · see citing works
Current and Future Treatments for Graves’ Disease and Graves’ Ophthalmopathy
Kotwal, A., & Stan, M. N. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0739-8134 · Cited by 40 · see citing works
McDermott, M. T. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202004070 · Cited by 35 · see citing works
Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
Kim, B. W. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab700 · Cited by 26 · see citing works
Phanthuwongpakdee, J., Babel, S., Laohhasurayotin, K., Sattayaporn, S., & Kaneko, T. (2020) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2020.104147 · Cited by 25 · see citing works
Taylor, P. N., Okosieme, O. E., Chatterjee, K., & Boelaert, K. (2019) · Clinical Endocrinology · doi:10.1111/cen.14136 · Cited by 19 · see citing works
Screening of New bio-based materials for radioactive iodide adsorption from water environment
Phanthuwongpakdee, J., Babel, S., & Kaneko, T. (2021) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2021.101955 · Cited by 17 · see citing works
Current Management of Radioiodine Sialadenitis
Hoffman, H. T., Chaudhry, U. S., Menda, Y., & Robinson, R. A. (2014) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-014-0041-1 · Cited by 11 · see citing works
Mortality Risk After Radioiodine Therapy for Hyperthyroidism: A Systematic Review and Meta-Analysis
Yan, D., Chen, C., Yan, H., Liu, T., Yan, H., & Yuan, J. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.10.018 · Cited by 9 · see citing works
Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma
Bešič, N., & Gazić, B. (2020) · Radiology and Oncology · doi:10.2478/raon-2020-0023 · Cited by 8 · see citing works
Shifting Trends and Informed Decision-Making in the Management of Graves' Disease
Seib, C. D., Chen, J., & Iagaru, A. H. (2020) · Thyroid · doi:10.1089/thy.2020.0114 · Cited by 6 · see citing works
Radiation Safety in Nuclear Medicine: Report I. Topical Problems
Narkevich, B. Y. (2021) · Medical Radiology and radiation safety · doi:10.12737/1024-6177-2021-66-1-29-36 · Cited by 5 · see citing works
Anion-Scavenging Biopolyamides from Quaternized 4-Aminocinnamic Acid Photodimers
Phanthuwongpakdee, J., Babel, S., Dwivedi, S., Takada, K., Hirayama, T., & Kaneko, T. (2020) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.9b07003 · Cited by 5 · see citing works
Miszczyk, J. U., Gałaś, A., Panek, A., Kowalska, A., Kostkiewicz, M., Borkowska, E., & Brudecki, K. (2022) · Cells · doi:10.3390/cells11101655 · Cited by 4 · see citing works
Actual problems of nuclear medicine in pediatrics (review)
NMRCO, N. N. B., Krylov, A. S., Narkevich, B. Y., NMRCO, N. N. B., Ryzhkov, A. D., & NMRCO, N. N. B. (2021) · Radiation and Risk Bulletin of the National Radiation and Epidemiological Registry · doi:10.21870/0131-3878-2021-30-4-69-84 · Cited by 3 · see citing works
Histamine Receptor 1 and 2 Antagonists Alter Biodistribution of Radioiodine
Edwards, O., Yakish, E. D., Wang, L.-M., Wu, Q., Hoffman, J. M., & Morton, K. A. (2015) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.115.160697 · Cited by 3 · see citing works
Methodological Basis of Nuclear Medicine in Pediatric
Krylov, A. S., Narkevich, B. Y., & Ryzhkov, A. D. (2022) · Journal of oncology diagnostic radiology and radiotherapy · doi:10.37174/2587-7593-2022-5-1-18-36 · Cited by 2 · see citing works
Ung, K. A., Portillo, M., Moran, B., Kron, T., Sawyer, B., Herschtal, A., & Chua, B. H. (2013) · Practical Radiation Oncology · doi:10.1016/j.prro.2012.12.007 · Cited by 2 · see citing works
Self-citationRAI Therapy for Graves’ Hyperthyroidism
Iakovou, I. P., Giannoula, E. I., Exadaktylou, P., & Papadopoulos, N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96083 · Cited by 3 · see citing works
Radioiodine Treatment of Hyperthyroidism
Luster, M., & Laßmann, M. (2022) · doi:10.1093/med/9780198870197.003.0060 · Cited by 1 · see citing works
Sakr, M. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-48775-1_6 · Cited by 1 · see citing works
Nongenetic risk factors for thyroid cancer: an umbrella review of evidence
Peng, G., Pan, X., Ye, Z., Yi, X., Xie, Q., Zhang, X., & Tong, N. (2025) · Endocrine · doi:10.1007/s12020-024-04155-x · Cited by 1 · see citing works
Radioactive Iodine Therapy for Hyperthyroidism Is Associated with Increased Solid Cancer Mortality
Toft, D. J. (2019) · Clinical Thyroidology · doi:10.1089/ct.2019;31.326-329 · Cited by 1 · see citing works
Iodine-131 administration and risk of cancer: “Appearances can be deceptive”
Salvatori, M., Treglia, G., Perotti, G., & Giovanella, L. (2013) · HORMONES · doi:10.14310/horm.2002.1417 · Cited by 1 · see citing works
Hyperthyroidism in Graves’ Disease
Covelli, D., & Salvi, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98496-4 · Cited by 1 · see citing works
Bartalena, L. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_17
Uptake and effect of radioiodine exposure on SKBR-3 cell lines
Irramah, M., Kurniawati, Y., Susilo, V., Setiyowati, S., & Elliyanti, A. (2019) · Majalah Kedokteran Andalas · doi:10.25077/mka.v43.i1.p23-28.2020
Zhu, G., & Vargas-Uricoehea, H. (2021) · Universal Journal of Pharmaceutical Research · doi:10.22270/ujpr.v6i3.610
Bartalena, L. (2016) · Endocrinology · doi:10.1007/978-3-319-29195-6_17-1
Radionuclide Therapy in Benign Thyroid Diseases: Graves’ Disease
Araz, M., & Özkan, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-97220-2_5
Mirjalili, S. R., Razmpoosh, E., Eshraghi, R., Ashoori, M., & Soltani, S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf580 · Cited by 1 · see citing works
Jack, L., Izhar, A., Gomez‐Carrillo, D., Swaminathan, N., & Chen, H. (2026) · Radiation · doi:10.3390/radiation6040042
- Authors
- Hieu, T. T., Russell, A. W., Cuneo, R., Clark, J., Kron, T., Hall, P., & Doi, S. A. R.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Doi, Suhail A R
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2012-07-31
- Volume
- 19
- Issue
- 5
- Pages
- 645-655
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2100437654
- Cited by
- 50
- References
- 62
- Citations by year
- 2026: 1 · 2025: 2 · 2022: 4 · 2021: 7 · 2020: 10 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 5 · 2012: 1
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Related Cancer (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiation Dose and Imaging
- Keywords
- benign thyroid disease, cancer risk, radiation-induced cancer, thyroid cancer, kidney cancer, gastric cancer, technetium-99m pertechnetate
- MeSH terms
- Humans, Iodine Radioisotopes, Neoplasms, Risk, Thyroid Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review